Ruventa Pharma Private Limited - Company Profile

It is a trading private limited company based in Nagpur, Maharashtra, India, established in 2018.
2018 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Ruventa Pharma Private Limited

Ruventa Pharma Private Limited, a active private limited company, was established on 13 March 2018 in Nagpur, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909MH2018PTC306430. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Yunusbaig Mateenbaig Mirza (Director), Mirza Ilyaas Baig (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at House No. 1212/A/29 Samaj, Behind Ayappa Temple,, Nagpur, Maharashtra, 440013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2018PTC306430

  • Registration Number

    306430

  • Incorporation Date

    13 March 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 10 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** %
  • Profit Growth **** 76.03%
  • Ebitda **** 92.05%
  • Net Worth -16.18%
  • Total Assets **** 62.35%
Company report

Ruventa Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ruventa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ruventa Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Yunusbaig Mateenbaig Mirza Director 13 Mar 2018 Current
Mirza Ilyaas Baig Director 13 Mar 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ruventa Pharma.

Ruventa Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 76.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.18%.

Ruventa Pharma revenue growth over time
Ruventa Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 62.35%
*******
*******
*******
*******
Profit or Loss
*******
 76.03%
*******
*******
*******
*******
Net Worth
*******
 -16.18%
*******
*******
*******
*******
EBITDA
*******
 92.05%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ruventa Pharma?

Unlock access to Ruventa Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ruventa Pharma?

Unlock and access historical data on people associated with Ruventa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ruventa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruventa Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ruventa Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ruventa Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.

  • Balance Sheet

    Ruventa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Yunusbaig Mateenbaig Mirza was appointed as a Director was appointed as a Director on 13 Mar 2018 & has been associated with this company since 7 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Mirza Ilyaas Baig was appointed as a Director was appointed as a Director on 13 Mar 2018 & has been associated with this company since 7 years 10 months . was documented.

  • Company Incorporation

    Ruventa Pharma Private Limited was registered on 13 Mar 2018 with Roc Mumbai & aged 7 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ruventa Pharma Private Limited?

The CIN of Ruventa Pharma Private Limited is U51909MH2018PTC306430.

Where is Ruventa Pharma Private Limited headquartered?

Ruventa Pharma Private Limited is headquartered at House No. 1212/A/29 Samaj, Behind Ayappa Temple,, Nagpur, Maharashtra, 440013.

When was Ruventa Pharma Private Limited incorporated?

Ruventa Pharma Private Limited was incorporated on 13 March 2018.

Who are the current directors of Ruventa Pharma Private Limited?

The current directors of Ruventa Pharma Private Limited are

What is the primary industry of Ruventa Pharma Private Limited?

The primary industry of Ruventa Pharma Private Limited is Trading.

Is Ruventa Pharma Private Limited a listed company?

Ruventa Pharma Private Limited is unlisted.

What is the capital structure of Ruventa Pharma Private Limited?

The authorized capital of Ruventa Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available